Groowe Groowe BETA / Newsroom
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

Molecular Cytogenetics - Global Strategic Business Report: Capitalize on 8.8% CAGR to US$3.5 Billion by 2030; Outmaneuver Abbott, Agilent, Bio-Rad, Illumina and Roche Amid Tariff Shifts

globenewswire.com
ABT Abbott Laboratories is mentioned as a competitor in the molecular cytogenetics market, with the report analyzing competitive positioning and strategies. No specific positive or negative performance is indicated. A Agilent Technologies is listed as a competitor in the molecular cytogenetics market. The article discusses competitive landscape and strategies but provides no specific sentiment towards Agilent. BIO Bio-Rad Laboratories is identified as a competitor within the molecular cytogenetics market. The report focuses on market analysis and competitive positioning, not specific company performance. ILMN Illumina is mentioned as a competitor in the molecular cytogenetics market. The article provides a general overview of the competitive landscape and market trends, without specific sentiment towards Illumina.

Molecular Cytogenetics - Global Strategic Business Report: Capitalize on 8.8% CAGR to US$3.5 Billion by 2030; Outmaneuver Abbott, Agilent, Bio-Rad, Illumina and Roche Amid Tariff Shifts Dublin, Nov. 11, 2026 (GLOBE NEWSWIRE) -- "Molecular Cytogenetics - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.

The global molecular cytogenetics market was valued at US$2.1 billion in 2024 and is projected to reach US$3.5 billion by 2030, expanding at a compound annual growth rate (CAGR) of 8.8% from 2024 to 2030. The comprehensive market report examines industry trends, growth drivers, competitive developments, regional opportunities, and forecasts to support informed strategic planning. It also assesses recent global tariff developments and their impact on molecular cytogenetics supply chains, sourcing strategies, costs, and market expansion.

Global Molecular Cytogenetics Market Trends and Growth Drivers

Technologies including fluorescence in situ hybridization (FISH), comparative genomic hybridization (CGH), array CGH, immunohistochemistry, and karyotyping support the detection and analysis of chromosomal abnormalities and genetic variations. These capabilities are increasingly important in genetic disorder diagnosis, oncology, prenatal screening, clinical research, and personalized medicine.

Technological advances are strengthening the accuracy, speed, and clinical utility of molecular cytogenetics. High-throughput sequencing, next-generation sequencing, microarrays, automation, and bioinformatics platforms are improving the identification and interpretation of complex genomic alterations. These developments are also extending molecular cytogenetics applications into population genetics, evolutionary biology, translational research, and precision oncology.

Market growth is being supported by the rising prevalence of cancer and genetic disorders, increasing adoption of personalized medicine, and continued investment in genomics research. Expanding healthcare infrastructure and greater access to advanced diagnostic technologies are further accelerating adoption across clinical laboratories, pharmaceutical and biotechnology companies, and academic research institutions. Ongoing product innovation and more cost-effective genetic testing are expected to create additional commercial opportunities through 2030.

Market Segment and Regional Outlook

The consumables segment is forecast to reach US$2 billion by 2030, growing at a CAGR of 8.9%. The instruments segment is expected to record a CAGR of 7.8% over the analysis period. Recurring demand for probes, reagents, assay kits, and laboratory supplies is anticipated to reinforce the position of consumables within the global molecular cytogenetics market.

The U.S. molecular cytogenetics market was valued at US$939.5 million in 2024. China is forecast to grow at a CAGR of 10.1% and reach US$231.4 million by 2030. The report also evaluates opportunities across Canada, Japan, Germany, France, Italy, the UK, Spain, Russia, India, Australia, South Korea, Brazil, Mexico, the Middle East, Africa, and other major regional markets.

Domain Expert Insights

The report tracks annual market value, segment performance, regional demand, technology adoption, competitive positioning, and industry developments through 2030. Its analysis incorporates historical data from 2015 to 2023 alongside updated forecasts reflecting economic uncertainty, tariff effects, supply chain disruption, and structural changes in global trade.

Expert commentary from economists, trade specialists, and industry professionals examines how sourcing realignment, cross-border trade policies, and evolving tariff negotiations across more than 180 countries may affect market participants. The report also reviews population, urbanization, healthcare investment, innovation, and other economic indicators influencing long-term molecular cytogenetics market prospects.

Competitive Landscape and Companies

The report provides company profiles, market presence analysis, and competitive intelligence covering established and emerging participants. Featured companies include Abbott Laboratories, Inc.; Abbott Molecular, Inc.; Agilent Technologies, Inc.; Bio-Rad Laboratories, Inc.; Illumina, Inc.; F. Hoffmann-La Roche AG; Eurofins Scientific SE; GeneDx; Empire Genomics LLC; BioDiscovery, Inc.; FUJIFILM Irvine Scientific; ADS Biotec, Inc.; BIOVIEW Ltd.; Esperite NV; and CytoSport, Inc.

Updated competitive analysis includes 2025 global market share estimates and positioning of major companies across strong, active, niche, and limited-presence categories. Coverage also addresses product development, process innovation, emerging technologies, strategic partnerships, and the competitive strategies shaping the molecular cytogenetics industry.

Key Report Benefits

The study addresses how the global molecular cytogenetics market is expected to evolve through 2030, which segments are positioned for the strongest growth, how regional market shares may change, and which technological, economic, and competitive factors will shape future demand.

Key Attributes:

For more information about this report visit https://www.researchandmarkets.com/r/qe9tfh

About ResearchAndMarkets.com

ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.